<VariationArchive VariationID="817659" VariationName="NM_001127222.2(CACNA1A):c.471dup (p.Ala158fs)" VariationType="Duplication" Accession="VCV000817659" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-05" DateCreated="2020-03-16" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="806037" VariationID="817659">
      <GeneList>
        <Gene Symbol="CACNA1A" FullName="calcium voltage-gated channel subunit alpha1 A" GeneID="773" HGNC_ID="HGNC:1388" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13206442" stop="13506479" display_start="13206442" display_stop="13506479" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13317255" stop="13617273" display_start="13317255" display_stop="13617273" Strand="-" />
          </Location>
          <OMIM>601011</OMIM>
          <Haploinsufficiency last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001127222.2(CACNA1A):c.471dup (p.Ala158fs)</Name>
      <CanonicalSPDI>NC_000019.10:13452943:AAA:AAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19p13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13452943" stop="13452944" display_start="13452943" display_stop="13452944" variantLength="1" positionVCF="13452943" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13563757" stop="13563758" display_start="13563757" display_stop="13563758" variantLength="1" positionVCF="13563757" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>A158fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127221.1" sequenceAccession="NM_001127221" sequenceVersion="1" change="c.471dupT">
            <Expression>NM_001127221.1:c.471dupT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.13452946dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.13452946dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.13563760dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.13563760dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011569.1" sequenceAccession="NG_011569" sequenceVersion="1" change="g.58517dup">
            <Expression>NG_011569.1:g.58517dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000068.4" sequenceAccession="NM_000068" sequenceVersion="4" change="c.471dup">
            <Expression>NM_000068.4:c.471dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000059.3" sequenceAccession="NP_000059" sequenceVersion="3" change="p.Ala158fs">
            <Expression>NP_000059.3:p.Ala158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127221.2" sequenceAccession="NM_001127221" sequenceVersion="2" change="c.471dup">
            <Expression>NM_001127221.2:c.471dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120693.1" sequenceAccession="NP_001120693" sequenceVersion="1" change="p.Ala158fs">
            <Expression>NP_001120693.1:p.Ala158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127222.2" sequenceAccession="NM_001127222" sequenceVersion="2" change="c.471dup" MANESelect="true">
            <Expression>NM_001127222.2:c.471dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120694.1" sequenceAccession="NP_001120694" sequenceVersion="1" change="p.Ala158fs">
            <Expression>NP_001120694.1:p.Ala158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001174080.2" sequenceAccession="NM_001174080" sequenceVersion="2" change="c.471dup">
            <Expression>NM_001174080.2:c.471dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001167551.1" sequenceAccession="NP_001167551" sequenceVersion="1" change="p.Ala158fs">
            <Expression>NP_001167551.1:p.Ala158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_023035.3" sequenceAccession="NM_023035" sequenceVersion="3" change="c.471dup">
            <Expression>NM_023035.3:c.471dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_075461.2" sequenceAccession="NP_075461" sequenceVersion="2" change="p.Ala158fs">
            <Expression>NP_075461.2:p.Ala158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_7" sequenceAccession="LRG_7">
            <Expression>LRG_7:g.58517dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_7t1" sequenceAccession="LRG_7t1">
            <Expression>LRG_7t1:c.471dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_7p1" sequenceAccession="LRG_7p1" change="p.Ala158fs">
            <Expression>LRG_7p1:p.Ala158fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1599289383" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001127222.2(CACNA1A):c.471dup (p.Ala158fs) AND not provided" Accession="RCV001008862" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001127222.2(CACNA1A):c.471dup (p.Ala158fs) AND multiple conditions" Accession="RCV003769415" Version="1">
        <ClassifiedConditionList TraitSetID="39917">
          <ClassifiedCondition DB="MedGen" ID="C4310716">Developmental and epileptic encephalopathy, 42</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1720416">Episodic ataxia type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-28" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-03-16" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10371528</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19486177</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25735478</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27250579</ID>
        </Citation>
        <DescriptionHistory Dated="2022-04-16">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="39917" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36150" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 42</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 42</ElementValue>
                <XRef ID="MONDO:0014917" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE42</ElementValue>
                <XRef Type="MIM" ID="617106" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16191" />
                <XRef ID="16191" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C4310716" DB="MedGen" />
              <XRef ID="MONDO:0014917" DB="MONDO" />
              <XRef Type="MIM" ID="617106" DB="OMIM" />
            </Trait>
            <Trait ID="1620" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nystagmus-associated episodic ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Episodic ataxia type 2</ElementValue>
                <XRef ID="Episodic+Ataxia+with+Nystagmus/2620" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007163" DB="MONDO" />
                <XRef ID="420932006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebellopathy, hereditary paroxysmal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia, familial, paroxysmal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetazolamide-responsive, hereditary, paroxysmal, cerebellar ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetazolamide-responsive episodic ataxia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebellar ataxia, paroxysmal, Acetazolamide-responsive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Episodic ataxia with nystagmus</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EA2</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">APCA</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CAPA</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9602" />
                <XRef ID="9602" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <XRef ID="97" DB="Orphanet" />
              <XRef ID="C1720416" DB="MedGen" />
              <XRef ID="MONDO:0007163" DB="MONDO" />
              <XRef Type="MIM" ID="108500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2306660" SubmissionDate="2022-04-13" DateLastUpdated="2023-03-04" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDXSV:224399" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001168667" DateUpdated="2023-03-04" DateCreated="2020-03-16" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge; Not observed in large population cohorts (gnomAD)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA1A" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1952319</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001127221.1:c.471dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_100_20220413054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_49_20210923044204</SubmissionName>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8559069" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="30736343|MedGen:C4310716;C1720416" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004604566" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10371528</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19486177</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25735478</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27250579</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala158Cysfs*33) in the CACNA1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CACNA1A are known to be pathogenic (PMID: 10371528, 19486177, 25735478, 27250579). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CACNA1A-related conditions. ClinVar contains an entry for this variant (Variation ID: 817659). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.13563757_13563758insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4310716" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1720416" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8559069" TraitType="Disease" MappingType="XRef" MappingValue="C4310716" MappingRef="MedGen">
        <MedGen CUI="C4310716" Name="Developmental and epileptic encephalopathy, 42" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8559069" TraitType="Disease" MappingType="XRef" MappingValue="C1720416" MappingRef="MedGen">
        <MedGen CUI="C1720416" Name="Episodic ataxia type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2306660" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

